Changes in the sensitivity of frontal cortical neurones to acetylcholine after unilateral lesion of the nucleus basalis with α-amino-3-OH-4-isoxozole propionic acid (AMPA): Effects of basal forebrain transplants into neocortex

Brain Research Bulletin

Volumn 42, Issue 3, 1997, Pages 169-186

  Abdulla, Fuad A ^a   Calaminici, Mariarita ^b   Gray, Jeffrey A ^a   Sinden, John D ^a   Stephenson, John D ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Acetylcholine Oxotremorine; AMPA; Carbachol; Frontal cortex; Hyoscine; Nucleus basalis; Transplantation

Indexed keywords

ACETYLCHOLINE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CARBACHOL; GLUTAMIC ACID; MUSCARINIC RECEPTOR; OXOTREMORINE; SCOPOLAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TRANSPLANTATION; CELL LOSS; CHOLINERGIC SYSTEM; CONTROLLED STUDY; FETUS; FOREBRAIN; FRONTAL CORTEX; MALE; NEOCORTEX; NERVE PROJECTION; NONHUMAN; OLIVARY NUCLEUS; PRIORITY JOURNAL; RAT;

ACETYLCHOLINE; ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; CEREBRAL CORTEX; FRONTAL LOBE; MALE; PROSENCEPHALON; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA INNOMINATA;

EID: 0031035552     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(96)00213-4     Document Type: Article

References (72)

1. Abdulla F. A., Calaminici M.-R., Gray J. A., Sinden J. D., Stephenson J. D. Chronic hyoscine and oxotremorine treatment alter the sensitivity of rat frontal cortex pyramidal cells to acetylcholine and carbachol. Br. J. Pharmacol. 106:1992;39P.
2. Abdulla F. A., Calaminici M.-R., Sinden J. D., Stephenson J. D. Effects of AMPA lesions of NBM and subsequent embryonic transplants on cortical serotonergic mechanisms in rats. Soc. Neurosci. Abstr. 19:1993;1151.
3. Abdulla F. A., Calaminici M.-R., Raevsky V., Sinden J. D., Gray J. A., Stephenson J. D. An iontophoretic study of the effects of α -amino-hydroxy-5-methyl-4-isoxazole propionic acid lesions of the nucleus basalis magnocellularis on cholinergic and GABAergic influences on frontal cortex neurones of rats. Exp. Brain Res. 98:1994;441-456.
4. Abdulla F. A., Calaminici M.-R., Sinden J. D., Stephenson J. D. Effects of unilateral AMPA lesion of nucleus basalis magnocellularis (nbm) and subsequent fetal basal forebrain transplants on cortical GABAergic mechanisms in rats. Br. J. Pharmacol. 111:1994;92P.
5. Abdulla, F. A.; Calaminici, M.-R.; Gray, J. A.; Sinden, J. D.; Stephenson, J. D. Fetal cholinergic transplants normalise frontal cortex neurones sensitivity to ACh increased by lesioning nucleus basalis magnocellularis (nbm). Proc. XXXIInd Int. Cong. Physiol. Sci., Glasgow; 1994:89.
6. Abdulla F. A., Calaminici M.-R., Stephenson J. D., Sinden J. D. Unilateral AMPA lesions of nucleus basalis magnocellularis induce a sensorimotor deficit which is differentially altered by arecoline and nicotine. Behav. Brain Res. 60:1994;161-169.
7. Adams I. Plasticity of synaptic contact zone following loss of synapses in the cerebral cortex of ageing human. Brain Res. 424:1987;343-351.
8. Altman H., Crossland R., Jenden D., Berman R. Further characterizations of the nature of behavioural and neurochemical effects of lesions to nucleus basalis of Meynert in the rat. Neurobiol. Aging. 6:1985;125-130.
9. Bartus R. T., Dean R. L., Beer B., Lippa A. S. The cholinergic hypothesis of geriatric memory dysfunction. Science. 217:1982;408-417.
10. Bartus R. T., Flicker C., Dean R. L., Pontecorvo M. J., Figuerido J. C., Fisher S. K. Selective memory loss following nucleus basalis lesions: Long term behavioural recovery despite persistent cholinergic deficiencies. Pharmacol. Biochem. Behav. 23:1985;125-135.
11. Belardetti F., Borgia R., Mancia M. Proencephalic mechanisms of ECoG desynchronization in cerveau isolé cats. EEG. Clin. Neurophysiol. 42:1977;213-235.
12. Ben-Barak J., Gazit H., Silman I., Dudai Y. In vivo modulation of the number of muscarinic receptors in rat brain by cholinergic ligands. Eur. J. Pharmacol. 74:1981;73-81.
13. Benson D. M., Blitzer R. D., Haroutunian V., Landau E. M. Functional muscarinic supersensitivity in denervated rat hippocampus. Brain Res. 478:1989;399-402.
14. Berman R. F., Crosland R. D., Jenden D. J., Altman H. J. Persisting behavioural and neurochemical deficits in rats following lesions of the basal forebrain. Pharmacol. Biochem. Behav. 29:1988;581-586.
15. Bird S. J., Aghajanian G. K. Denervation supersensitivity in the cholinergic septo-hippocampal pathway: A microiontophoretic study. Brain Res. 100:1975;355-370.
16. Bradbury E. J., Kershaw T. R., Marchbanks R. M., Sinden J. D. Astrocyte transplants alleviate lesion induced memory deficits independently of cholinergic recovery. Neuroscience. 65:1995;955-972.
17. Buzsáki G., Bicford R. G., Ponomareff G., Thal L., Mandel R., Gage H. Nucleus basalis and thalamic control of neocortical activity in the freely moving rat. J. Neurosci. 8:1988;4007-4026.
18. Buzsáki G., Masliah E., Chen L. S., Horvath Z., Terry R., Gage F. H. Hippocampal grafts into the intact brain induce epileptic patterns. Brain Res. 554:1991;30-37.
19. Calaminici M.-R., Abdulla F. A., Sinden J. D., Stephenson J. D. Direct evidence for axonal outgrowth from cholinergic grafts to cholinergically-deafferented rat cortex. Neuroreport. 4:1993;585-587.
20. Calaminici M.-R., Abdulla F. A., Sinden J. D., Stephenson J. D. Plastic changes in the cholinergic innervation of the rat cerebral cortex after unilateral lesion of the nucleus basalis with α -amino-3-OH-4-isoxozole propionic acid (AMPA): Effects of basal forebrain transplants into neocortex. Brain Res. Bull. 42:1997;79-93.
21. Casamenti F., Deffenu G., Abbamondi A. L., Pepeu G. Changes in cortical acetylcholine output induced modulation of the nucleus basalis. Brain Res. Bull. 16:1986;689-695.
22. Dawson V. L., Hunt M. E., Wamsley J. K. Alteration in cortical muscarinic receptors following cholinotoxin (AF64A) lesion of the rat nucleus basalis magnocellularis. Neurobiol. Aging. 13:1992;25-32.
23. DeKosky S. T., Scheff S. W. Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity. Ann. Neurol. 27:1990;457-464.
24. Detari L., Vanderwolf C. H. Activity of identified cortically projecting and other basal forebrain neurones during large slow waves and cortical activation in anaesthetized rats. Brain Res. 437:1987;1-8.
25. Dunnett S. B., Björklund A. Mechanisms of function of neural grafts in the adult mammalian brain. J. Exp. Biol. 132:1987;265-289.
26. Emson P. C., Lindvall O. Distribution of putative neurotransmitters in the neocortex. Neuroscience. 4:1979;1-30.
27. Fine A., Dunnett S. B., Björklund A., Clarke D., Iversen S. D. Transplantation of embryonic ventral forebrain neurons to the neocortex of rats with lesions of nucleus basalis magnocellularis - I. Biochemical and anatomical observation. Neuroscience. 16:1985;769-786.
28. Fisher S. K., Kilnger P. D., Agranoff B. Muscarinic agonist binding and phospholipid turnover in brain. J. Biol. Chem. 258:1983;7358-7363.
29. Gage F. H., Björklund A. Enhanced graft survival in the hippocampus following selective denervation. Neuroscience. 17:1986;89-98.
30. Gonzales R. A., Crews F. T. Characterization of cholinergic stimulation of phosphoinositide hydrolysis in rat brain slices. J. Neurosci. 4:1984;3120-3127.
31. Gray J. A., Sinden J. D., Hodges H. Cognitive function: neural degeneration and transplantation. Semi. the Neurosci. 2:1990;133-142.
32. Hall R. D., Lindholm E. P. Organization of motor and somatosensory neocortex in the albino rat. Brain Res. 66:1974;23-38.
33. Hartgraves S. L., Mensah P. L., Kelly P. H. Regional decreases of cortical acetyltransferase after lesions of the septal area and in the area of nucleus basalis magnocellularis. Neuroscience. 7:1982;2369-2376.
34. Hepler J. D., Olton D. S., Wenk G. L., Coyle J. T. Lesions in nucleus basalis magnocellularis and medial septal area of rats produce qualitatively similar memory impairment. J. Neurosci. 5:1985;866-873.
35. Hillman D. E., Chen S. Compensation in the number of pre-synaptic dense projections and synaptic vesicles in remaining parallel fibres following cerebellar lesions. J. Neurocytol. 14:1985;673-687.
36. Katayama S., Kito S., Yamamura Y. Increase of muscarinic receptor following kainic acid lesions of nucleus basalis magnocellularis in rat brain: An autoradiographic study. Res. Commun. Chem. Pathol. Pharmacol. 68:1990;391-394.
37. Koelle G. B. Anticholinesterase agents. Goodman L. S., Gillman A. G. The pharmacological basis of therapeutics. 1975;445-466 McMillan, New York.
38. Lamour Y., Dutar P., Jobert A. Spread of acetylcholine sensitivity in the neocortex following lesion of the nucleus basalis. Brain Res. 252:1982;377-381.
39. Lin Y., Phillis J. W. Chronic caffine exposure reduces the excitant action of acetylcholine on cerebral cortical neurones. Brain Res. 524:1991;316-318.
40. Lysakowski A., Wainer B. H., Bruce G., Hersh L. B. An atlas of the regional and laminar distribution of choline acetyltransferase immunoreactivity in rat cerebral cortex. Neuroscience. 28:1989;291-336.
41. Mandel R. J., Chen A. D., Connor D. J., Thal L. J. Continuous physostigmine infusion in rats with excitotoxic lesions of the nucleus basalis magnocellularis: effects on performance in the water maze task and cholinergic markers. J. Pharmacol. Exp. Ther. 251:1989;612-619.
42. Marks M. J., Artman L. D., Patinkin D. M., Collins A. C. Cholinergic adaptations to chronic oxotremorine infusion. J. Pharmacol. Exp. Ther. 218:1981;337-343.
43. Marks M. J., Artman L. D., Collins A. C. Quantitation of tolerance development after chronic oxotremorine treatment. Pharmacol. Biochem. Behav. 19:1983;103-113.
44. Marks M. J., Collins A. C. Tolerance, cross tolerance and receptors after chronic nicotine or oxotremorine. Pharmacol. Biochem. Behav. 22:1985;283-291.
45. Mash D. C., Flynn D. D., Potter L. T. Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental denervation. Science. 228:1985;115-117.
46. McKinney M., Coyle J. T. Regulation of neocortical muscarinic receptors: Effects of drug treatment and lesions. J. Neurosci. 2:1982;97-105.
47. McKinney M., Coyle J. T., Hedreen J. C. Topographic analysis of innervation of the rat neocortex and hippocampus by the basal forebrain cholinergic system. J. Comp. Neurol. 217:1983;103-121.
48. Metherate R., Ashe J. H. Basal forebrain stimulation modifies auditory cortex responsiveness by an action at muscarinic receptors. Brain Res. 559:1991;163-167.
49. Nieto-Sampedro M., Luis E. R., Cotman C. W., Manthorpe M., Skaper S. D., Barbin G., Longo F. M., Varon S. Brain injury causes a time-dependent increase in neuronotrophic activity at the lesion site. Science. 217:1982;860-861.
50. Nilsson O. G., Leanza G., Rosenblad C., Lippa D. A., Wiley R. G., Björklund A. Spatial learning impairments in rats with selective immunolesion of the forebrain cholinergic system. Neuroreport. 3:1992;1005-1008.
51. Pedigo N. W., Polk D. M. Reduced muscarinic receptor plasticity in frontal cortex of aged rats after chronic administration of cholinergic drugs. Life Sci. 37:1985;1443-1449.
52. Pietrzak E. R., Wilce P. A., Shanley B. C. Plasticity of brain muscarinic receptors in aging rats: The adaptive response to scopolamine and ethanol treatment. Neurosci. Lett. 104:1989;331-335.
53. Pilch H., Muller W. E. Chronic treatment with choline or scopolamine indicates the presence of muscarinic cholinergic receptor plasticity in the frontal cortex of young but not of aged mice. J. Neural. Transm. 71:1988;39-43.
54. Rasmusson D. D., Dykes R. W. Long-term enhancement of evoked potentials in cat somatosensory cortex produced by co-activation of the basal forebrain and cutaneous receptors. Exp. Brain Res. 70:1988;276-286.
55. Raulli R. E., Arendash G., Crews F. Effects of nbm lesions on muscarinic- stimulation of phosphoinositide hydrolysis. Neurobiol. Aging. 10:1989;191-197.
56. Reed L. J., De Bellerode J. Increased polyphosphoinositide responsiveness in the cerebral cortex induced by cholinergic denervation. J. Neurochem. 50:1988;1566-1571.
57. Rosenblad C., Nilsson O. G. Basal forebrain grafts in the rat neocortex restore in vivo acetylcholine release and respond to behavioural activation. Neuroscience. 55:1993;353-362.
58. 3H]-vesamicol binding in the temporal cortex of patients with Alzheimer's disease, Parkinson's disease, and rats with basal forebrain lesions. Neuroscience. 35:1990;327-333.
59. Russell R. W., Ehlert F. J., Hwa J. J. Relation between behaviourally augmented tolerance and up-regulation of muscarinic receptors in the CNS; Effects of chronic administration of scopolamine. Psychopharmacology (Berlin). 88:1986;33-39.
60. Sato H., Hata Y., Hagihara K., Tsumoto T. Effects of cholinergic depletion on neuron activities in the cat visual cortex. J. Neurophysiol. 58:1987;781-794.
61. Scarth B. J., Jhamandas K., Boegman R. J., Beninger R. J., Reynolds J. N. Cortical muscarinic receptor function following quinolinic acid-induced lesion of the nucleus basalis magnocellularis. Exp. Neurol. 103:1989;158-164.
62. Scheff S. W., DesKosky S. T., Price D. A. Quantitative assessment of cortical synaptic density in Alzheimer's disease. Neurobiol. Aging. 11:1990;29-37.
63. Shoham S., Newman M. E., Wertman E., Ebstein R. P. Cortical second messengers after NBM damage: No change in response to cholinergic agonists. Pharmacol. Biochem. Behav. 36:1990;507-513.
64. Stewart D. J., Macfabe D. F., Vanderwolf C. H. Cholinergic activation of electrocorticogram: role of the substantia innominata and effects of atropine and quinuclidinyl benzilate. Brain Res. 322:1984;219-232.
65. Swanson T. H., Phillis J. W. Effects of the muscarinic antagonists pirenzepine and gallamine on spontaneous and evoked responses of rat cerebral cortical neurones. Br. J. Pharmacol. 94:1988;192-198.
66. Van der Zee E. A., Matsuyama T., Strosberg A. D., Traber J., Luiten P. G. M. Demonstration of muscarinic acetylcholine receptor-like immunoreactivity in the rat forebrain and upper brainstem. Histochemistry. 92:1989;475-485.
67. Vige X., Briley M. Scopolamine induces up-regulation of nicotinic receptors in intact brain but not in nucleus basalis lesioned rats. Neurosci. Lett. 88:1988;319-324.
68. Watson M., Vickroy T. W., Fibiger H. C., Roeske W. R., Yamamura H. I. Effects of bilateral ibotenate-induced lesions of nucleus basalis magnocellularis upon selective cholinergic biochemical markers in the anterior cerebral cortex. Brain Res. 346:1985;387-391.
69. 3H]ketanserin (serotonin type 2) binding increases in rat cortex following basal forebrain lesions with ibotenic acid. J. Neurochem. 47:1986;845-850.
70. Werner G., Schmidt K. H. Chemische analyse des stoffwechsels von (-)-scopolamin beieingen saugelieren Hoppe-Seyler's Z. Physiol. Chem. Bd. 349:1968;741-752.
71. Woolf N. J. Cholinergic systems in mammalian brain and spinal cord. Prog. Neurobiol. 37:1991;475-524.
72. Abdulla, F. A.; Calaminici, M.-R.; Gray, J. A.; Stephenson, J. D.; Sinden, J. D. Behavioural specificity of neocortical grafts of fetal basal forebrain tissue after unilateral lesion of the nucleus basalis with α -amino-3-OH-4-isoxozole propionic acid (AMPA). Brain Res. Bull. (in press).